Clinical Trial Update: A Study for Participants With Spinal Muscular Atrophy (SMA) Who Previously Participated in Nusinersen (ISIS 396443) Investigational Studies [Phase 3]

View source ↗

Summary

Phase 3 trial update for spinal muscular atrophy patients who previously participated in nusinersen investigational studies; results have been posted following …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Muscular Atrophy

Drugs mentioned

• Spinraza (nusinersen)

Snippet

Sponsor: Biogen | Conditions: Spinal Muscular Atrophy | Phase 3 | Status: COMPLETED | Results posted: 2024-10-22